Ebovir Biotechnologie Inc. is a Quebec-based biotech focused on the AI-driven research and development of RNA-based therapeutics, mRNA vaccines, and molecular diagnostics targeting infectious diseases and cancer. With our lead R&D platform, Ebo-Pulmo™, we are developing a novel stem-loop RNA innate immune activator designed to stimulate antiviral interferon pathways. In parallel, we are engineering lung-targeted lipid nanoparticles (LNPs) for precise RNA delivery to respiratory tissues.
Backed by a dedicated scientific team and proprietary patented technologies, Ebovir is committed to advancing RNA innovation in Quebec and beyond, through active collaboration with academic institutions, clinical centers, and industry partners.
The medical R&D activities of Ebovir Biotechnologie Inc. described above are distinct from the EboScience cosmetic product line. EboScience products are for topical cosmetic use only and are not intended to diagnose, treat, or prevent any medical condition.
-
The science of exosomes highlights their role in carrying bio-active nutrients that help revitalize the skin's surface and enhance its natural resilience. -
Explore the EboScience Lab
Exosomes are tiny, membrane-bound extracellular vesicles (30-150 nm) that function as intercellular messengers, delivering essential proteins and lipids to support the skin's natural vitality and advanced rejuvenation.
Leveraging our proprietary patented technologies and rigorous scientific validation, we translate frontier life science research into high-performance skincare solutions.
